Canada markets closed

Blonder Tongue Laboratories, Inc. (BDRL)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1181-0.0218 (-15.55%)
At close: 03:24PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
13,213
13,213
18,115
15,754
16,379
Cost of Revenue
9,234
9,234
12,652
9,896
13,361
Gross Profit
3,979
3,979
5,463
5,858
3,018
Operating Expenses
Research Development
1,258
1,258
1,778
2,592
2,524
Selling General and Administrative
3,979
3,979
5,816
6,226
7,608
Total Operating Expenses
5,237
5,237
7,594
8,818
10,132
Operating Income or Loss
-1,258
-1,258
-2,131
-2,960
-7,114
Interest Expense
867
867
789
514
345
Total Other Income/Expenses Net
20
20
-
3,573
-
Income Before Tax
-2,105
-2,105
-2,920
99
-7,459
Income Tax Expense
12
12
0
15
15
Income from Continuing Operations
-2,117
-2,117
-2,920
84
-7,474
Net Income
-2,117
-2,117
-2,920
84
-7,474
Net Income available to common shareholders
-2,117
-2,117
-2,920
84
-7,474
Basic EPS
-0.10
-
-0.22
0.01
-0.76
Diluted EPS
-0.10
-
-0.22
0.01
-0.76
Basic Average Shares
13,729
-
13,281
12,151
9,898
Diluted Average Shares
13,729
-
13,281
15,450
9,898